Do incentives from Big Pharma influence the way doctors treat cancer patients? A study published earlier this year in JAMA Oncology says YES.
The first study to evaluate reimbursement policies and clinical care in oncology, the review found that oncologists often change their treatment recommendations and prescriptions based on incentives from the pharmaceutical industry.
Read more via Is Corporate Bribery Determining Your Cancer Treatment? — The Truth About Cancer
